日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Botensilimab, an Fc-Enhanced Anti-CTLA-4 Antibody, Is Effective against Tumors Poorly Responsive to Conventional Immunotherapy.

Botensilimab 是一种 Fc 增强型抗 CTLA-4 抗体,对传统免疫疗法反应不佳的肿瘤有效

Chand Dhan, Savitsky David A, Krishnan Shanmugarajan, Mednick Gabriel, Delepine Chloe, Garcia-Broncano Pilar, Soh Kah Teong, Wu Wei, Wilkens Margaret K, Udartseva Olga, Vincent Sylvia, Joshi Bishnu, Keith Justin G, Manrique Mariana, Marques Marilyn, Tanne Antoine, Levey Daniel L, Han Haiyong, Ng Serina, Ridpath Jackson, Huber Olivia, Morin Benjamin, Galand Claire, Bourdelais Sean, Gombos Randi B, Ward Rebecca, Qin Yu, Waight Jeremy D, Costa Matthew R, Sebastian-Yague Alvaro, Rudqvist Nils-Petter, Pupecka-Swider Malgorzata, Venkatraman Vignesh, Slee Andrew, Patel Jaymin M, Grossman Joseph E, Wilson Nicholas S, Von Hoff Daniel D, Stebbing Justin, Curiel Tyler J, Buell Jennifer S, O'Day Steven J, Stein Robert B

Fc-enhanced anti-CTLA-4, anti-PD-1, doxorubicin, and ultrasound-mediated blood-brain barrier opening: A novel combinatorial immunotherapy regimen for gliomas

Fc增强的抗CTLA-4、抗PD-1、阿霉素和超声介导的血脑屏障开放:一种治疗胶质瘤的新型联合免疫疗法方案

Kim, Kwang-Soo; Habashy, Karl; Gould, Andrew; Zhao, Junfei; Najem, Hinda; Amidei, Christina; Saganty, Ruth; Arrieta, Víctor A; Dmello, Crismita; Chen, Li; Zhang, Daniel Y; Castro, Brandyn; Billingham, Leah; Levey, Daniel; Huber, Olivia; Marques, Marilyn; Savitsky, David A; Morin, Benjamin M; Muzzio, Miguel; Canney, Michael; Horbinski, Craig; Zhang, Peng; Miska, Jason; Padney, Surya; Zhang, Bin; Rabadan, Raul; Phillips, Joanna J; Butowski, Nicholas; Heimberger, Amy B; Hu, Jian; Stupp, Roger; Chand, Dhan; Lee-Chang, Catalina; Sonabend, Adam M